AUO [AU OPTRONICS] 6-K:
[]
[This Form 6-K consists of: CONTENTS 2 Company Profile 4 Principal Financial Data and Indicators 6 Changes in Share Capital and Shareholdings of Principal Shareholders 8 Chairman’s Statement 10 Business Review and Prospects 14 Management’s Discussion and Analysis 25 Significant Events 35 Directors, Supervisors and Senior Management 36 Financial Statements 149 Documents for Inspection 150 Confirmation from the Directors and]
[This Form 6-K consists of: Announcement (a Sino-foreign joint stock limited company incorporated in the People's Republic of China) (Stock Code: 902) UNIT NO. 2 OF ANYUAN AND GUIDONG HANKOU WIND FARM COMMENCE OPERATION Huaneng Power International Inc. (the “Company”) announces that the 660 MW coal-fired generation unit No. 2 of the “Closing down smaller generation units and replaced with]
[Strategic Cooperation Agreement to Source Raw Plasma This Agreement is entered on August 28, 2015 by and between: Party A Party B Party C WHEREAS 1. Party A has certain source plasma inventory for producing blood products. Party A has financial difficulty in keeping the daily operation of its plasma collections stations. 2. Party B has the need for source] [FOR RELEASE September 2, 2015 China Biologic Enters into Strategic Collaboration Agreement to Source Raw BEIJING, China – September 2, 2015 – The raw plasma will be shipped in batches to Guizhou Taibang for the production of human albumin and IVIG products. The Company expects that the products made from the sourced raw plasma will begin to reach the market] []
[This Form 6-K consists of: Announcement (a Sino-foreign joint stock limited company incorporated in the People's Republic of China) (Stock Code: 902) UNIT NO. 2 OF ANYUAN AND GUIDONG HANKOU WIND FARM COMMENCE OPERATION Huaneng Power International Inc. (the “Company”) announces that the 660 MW coal-fired generation unit No. 2 of the “Closing down smaller generation units and replaced with]
[Strategic Cooperation Agreement to Source Raw Plasma This Agreement is entered on August 28, 2015 by and between: Party A Party B Party C WHEREAS 1. Party A has certain source plasma inventory for producing blood products. Party A has financial difficulty in keeping the daily operation of its plasma collections stations. 2. Party B has the need for source] [FOR RELEASE September 2, 2015 China Biologic Enters into Strategic Collaboration Agreement to Source Raw BEIJING, China – September 2, 2015 – The raw plasma will be shipped in batches to Guizhou Taibang for the production of human albumin and IVIG products. The Company expects that the products made from the sourced raw plasma will begin to reach the market] []
[OppenheimerFunds, Inc. IRS No. 13-2527171 2. Check the Appropriate Box if a Member of a Group (See Instructions): Joint filing 3. SEC Use Only 4. Citizenship or Place of Organization: Colorado Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power: 0 6. Shared Voting Power: 4,982,019 7. Sole Dispositive Power: 0 8. Shared Dispositive Power:]
[OppenheimerFunds, Inc. IRS No. 13-2527171 2. Check the Appropriate Box if a Member of a Group (See Instructions): Joint filing 3. SEC Use Only 4. Citizenship or Place of Organization: Colorado Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power: 0 6. Shared Voting Power: 4,982,019 7. Sole Dispositive Power: 0 8. Shared Dispositive Power:]